These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 35211118)

  • 1. Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease.
    Supino D; Minute L; Mariancini A; Riva F; Magrini E; Garlanda C
    Front Immunol; 2022; 13():804641. PubMed ID: 35211118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.
    Molgora M; Supino D; Mantovani A; Garlanda C
    Immunol Rev; 2018 Jan; 281(1):233-247. PubMed ID: 29247989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interleukin-1 family: back to the future.
    Garlanda C; Dinarello CA; Mantovani A
    Immunity; 2013 Dec; 39(6):1003-18. PubMed ID: 24332029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The family of the interleukin-1 receptors.
    Boraschi D; Italiani P; Weil S; Martin MU
    Immunol Rev; 2018 Jan; 281(1):197-232. PubMed ID: 29248002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC.
    Mariotti FR; Supino D; Landolina N; Garlanda C; Mantovani A; Moretta L; Maggi E
    Semin Immunol; 2023 Mar; 66():101712. PubMed ID: 36753974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulatory receptors of the IL-1 family.
    Garlanda C; Riva F; Bonavita E; Mantovani A
    Semin Immunol; 2013 Dec; 25(6):408-15. PubMed ID: 24239046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.
    Bonecchi R; Garlanda C; Mantovani A; Riva F
    Cytokine; 2016 Nov; 87():37-45. PubMed ID: 27498604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.
    Li S; Neff CP; Barber K; Hong J; Luo Y; Azam T; Palmer BE; Fujita M; Garlanda C; Mantovani A; Kim S; Dinarello CA
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2497-502. PubMed ID: 25654981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wandering pathways in the regulation of innate immunity and inflammation.
    Mantovani A
    J Autoimmun; 2017 Dec; 85():1-5. PubMed ID: 29079064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interleukin-1 receptor family.
    Boraschi D; Tagliabue A
    Semin Immunol; 2013 Dec; 25(6):394-407. PubMed ID: 24246227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Interleukin 1 Receptor 2 in Kidney Disease.
    Hu H; Wu A; Mu X; Zhou H
    J Interferon Cytokine Res; 2024 Apr; 44(4):170-177. PubMed ID: 38527174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and function of IL-1R8 (TIR8/SIGIRR): a regulatory member of the IL-1 receptor family in platelets.
    Anselmo A; Riva F; Gentile S; Soldani C; Barbagallo M; Mazzon C; Feruglio F; Polentarutti N; Somma P; Carullo P; Angelini C; Bacci M; Mendolicchio GL; Voza A; Nebuloni M; Mantovani A; Garlanda C
    Cardiovasc Res; 2016 Sep; 111(4):373-84. PubMed ID: 27297888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of IL-1 signaling by the decoy receptor IL-1R2.
    Schlüter T; Schelmbauer C; Karram K; Mufazalov IA
    J Mol Med (Berl); 2018 Oct; 96(10):983-992. PubMed ID: 30109367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity.
    Campesato LF; Silva APM; Cordeiro L; Correa BR; Navarro FCP; Zanin RF; Marçola M; Inoue LT; Duarte ML; Molgora M; Pasqualini F; Massara M; Galante P; Barroso-Sousa R; Polentarutti N; Riva F; Costa ET; Mantovani A; Garlanda C; Camargo AA
    Oncotarget; 2017 Jul; 8(30):49470-49483. PubMed ID: 28533483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the IL-1 family in innate inflammation and acquired immunity.
    Dinarello CA
    Immunol Rev; 2018 Jan; 281(1):8-27. PubMed ID: 29247995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1 and IL-1 regulatory pathways in cancer progression and therapy.
    Mantovani A; Barajon I; Garlanda C
    Immunol Rev; 2018 Jan; 281(1):57-61. PubMed ID: 29247996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Role of IL-1R8 in Immunity and Disease.
    Molgora M; Barajon I; Mantovani A; Garlanda C
    Front Immunol; 2016; 7():149. PubMed ID: 27148268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 Ligands and Receptors in Lumpfish (
    Eggestøl HØ; Lunde HS; Knutsen TM; Haugland GT
    Front Immunol; 2020; 11():502. PubMed ID: 32300342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
    Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
    Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction.
    Nold-Petry CA; Lo CY; Rudloff I; Elgass KD; Li S; Gantier MP; Lotz-Havla AS; Gersting SW; Cho SX; Lao JC; Ellisdon AM; Rotter B; Azam T; Mangan NE; Rossello FJ; Whisstock JC; Bufler P; Garlanda C; Mantovani A; Dinarello CA; Nold MF
    Nat Immunol; 2015 Apr; 16(4):354-65. PubMed ID: 25729923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.